An overseas listing not only enables a company to raise its brand awareness with potential customers, but it also enables them to access a more diverse investor pool. The Forum will focus on biotech companies looking to list on the Tokyo Stock Exchange (TSE). The biotech sector comprises more than 30 percent of the market capitalization of the TSE Mothers board. Our speakers will share their experiences of assisting U.S. companies list on the TSE, and present their views on the key issues and specific challenges of going public in Japan.

The Forum is hosted by Reed Smith and the Japan Exchange Group, with a keynote from Mr. Hidetoshi Nagata, Head of Global Listings at the Tokyo Stock Exchange, with presentations from Deloitte, Mizuho Securities, Mori Hamada & Matsumoto and Reed Smith.